Basho Chandan 4

What Happened
Basho Chandan, Astrana Health’s Chief Operating Officer and Chief Financial Officer, surrendered 8,155 shares on May 16, 2026. The shares were disposed at $38.26 each for a total value of $312,010. The Form 4 records the transaction as code "F" — payment of exercise price or tax liability — and the filing indicates the share surrender was to satisfy tax withholding obligations tied to restricted stock that vested the same day.

Key Details

• Transaction date and price: 2026-05-16, 8,155 shares at $38.26 each (total $312,010).
• Transaction code: F (tax withholding / payment of tax liability).
• Shares owned after transaction: Not explicitly stated in the Form 4. The filing does report unvested awards (see footnote).
• Notable footnotes:
  • F1: The 8,155-share surrender offset tax withholding on restricted stock that vested on May 16, 2026.
  • F2: Reporting includes unvested awards: 15,202 restricted shares vesting May 16, 2027 (subject to employment), plus RSUs of 15,604 (vesting in four equal semi-annual installments beginning Oct 2, 2026) and 20,027 (vesting in six equal semi-annual installments beginning Sep 5, 2026).
• Filing timeliness: Form filed 2026-05-18 for a 2026-05-16 transaction — appears to be timely (filed within the normal Form 4 reporting window).

Context
This was a tax-withholding share surrender tied to vesting restricted stock, not an open-market sale for cash or a purchase. Such surrenders are common when restricted awards vest and do not necessarily indicate a change in insider sentiment. The filing does not indicate a 10b5-1 plan or other sale plan; it simply documents shares surrendered to cover withholding and the remaining unvested award schedule.